BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 6303865)

  • 1. Transforming growth factors from neoplastic and nonneoplastic tissues.
    Roberts AB; Frolik CA; Anzano MA; Sporn MB
    Fed Proc; 1983 Jun; 42(9):2621-6. PubMed ID: 6303865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factors in solid human malignant neoplasms.
    Nickell KA; Halper J; Moses HL
    Cancer Res; 1983 May; 43(5):1966-71. PubMed ID: 6299535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of transforming growth factors in human breast cancer cells.
    Salomon DS; Zwiebel JA; Bano M; Losonczy I; Fehnel P; Kidwell WR
    Cancer Res; 1984 Sep; 44(9):4069-77. PubMed ID: 6331663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of growth responsiveness to epidermal growth factor and enhanced production of alpha-transforming growth factors in ras-transformed mouse mammary epithelial cells.
    Salomon DS; Perroteau I; Kidwell WR; Tam J; Derynck R
    J Cell Physiol; 1987 Mar; 130(3):397-409. PubMed ID: 3494020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of phorbol esters on the activity of purified transforming growth factors.
    Kraft AS
    Cancer Res; 1986 Apr; 46(4 Pt 1):1764-7. PubMed ID: 3004705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic interaction of two classes of transforming growth factors from murine sarcoma cells.
    Anzano MA; Roberts AB; Meyers CA; Komoriya A; Lamb LC; Smith JM; Sporn MB
    Cancer Res; 1982 Nov; 42(11):4776-8. PubMed ID: 6290046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor (TGF) activity in human urine: synergism between TGF-beta and urogastrone.
    Twardzik DR; Sherwin SA
    J Cell Biochem; 1985; 28(4):289-97. PubMed ID: 2997242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and biological properties of type beta transforming growth factor from mouse transformed cells.
    Fernandez-Pol JA; Klos DJ; Grant GA
    Cancer Res; 1986 Oct; 46(10):5153-61. PubMed ID: 3489522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of transforming growth factors produced by the insulin-independent teratoma-derived cell line 1246-3A.
    Yamada Y; Serrero G
    J Cell Physiol; 1989 Aug; 140(2):254-63. PubMed ID: 2663884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse Balb/c3T3 cell mutant with low epidermal growth factor receptor activity: induction of stable anchorage-independent growth by transforming growth factor beta.
    Kuratomi Y; Ono M; Yasutake C; Mawatari M; Kuwano M
    J Cell Physiol; 1987 Jan; 130(1):51-7. PubMed ID: 3468117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and partial purification of a new class of transforming growth factors from an avian sarcoma virus-transformed rat cell line.
    Hirai R; Yamaoka K; Mitsui H
    Cancer Res; 1983 Dec; 43(12 Pt 1):5742-6. PubMed ID: 6315215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonistic actions of retinoic acid and dexamethasone on anchorage-independent growth and epidermal growth factor binding of normal rat kidney cells.
    Roberts AB; Anzano MA; Lamb LC; Smith JM; Sporn MB
    Cancer Res; 1984 Apr; 44(4):1635-41. PubMed ID: 6322983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of anchorage-independent growth by epidermal growth factor and altered sensitivity to type beta transforming growth factor in partially transformed rat kidney cells.
    Newman MJ; Lane EA; Nugent MA; Racker E
    Cancer Res; 1986 Nov; 46(11):5842-50. PubMed ID: 3019539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct high-performance liquid chromatography pattern of transforming growth factor activity in urine of cancer patients as compared with that of normal individuals.
    Kimball ES; Bohn WH; Cockley KD; Warren TC; Sherwin SA
    Cancer Res; 1984 Aug; 44(8):3613-9. PubMed ID: 6331653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factors (TGFs): properties and possible mechanisms of action.
    Todaro GJ; De Larco JE; Fryling C; Johnson PA; Sporn MB
    J Supramol Struct Cell Biochem; 1981; 15(3):287-301. PubMed ID: 6267317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of intra- and extracellular transforming growth factors from nontransformed and chemically transformed mouse embryo cells.
    Tucker RF; Volkenant ME; Branum EL; Moses HL
    Cancer Res; 1983 Apr; 43(4):1581-6. PubMed ID: 6299525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factors.
    Roberts AB; Sporn MB
    Cancer Surv; 1985; 4(4):683-705. PubMed ID: 2890434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The purification of an acid- and heat-labile transforming growth factor from an avian sarcoma virus-transformed rat cell line.
    Yamaoka K; Hirai R; Tsugita A; Mitsui H
    J Cell Physiol; 1984 Jun; 119(3):307-14. PubMed ID: 6327732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial purification of transforming growth factors from human milk.
    Zwiebel JA; Bano M; Nexo E; Salomon DS; Kidwell WR
    Cancer Res; 1986 Feb; 46(2):933-9. PubMed ID: 3000589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic transformation of normal rat kidney cells in a growth-factor-defined medium: induction by a neuroblastoma-derived transforming growth factor independently of the EGF receptor.
    van Zoelen EJ; van Oostwaard TM; van der Saag PT; de Laat SW
    J Cell Physiol; 1985 May; 123(2):151-60. PubMed ID: 2984216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.